Aortic cross-clamp time, new prostheses, and outcome in aortic valve replacement

Journal of Heart Valve Disease

Volumn 21, Issue 6, 2012, Pages 732-739

  Ranucci, Marco ^a   Frigiola, Alessandro ^a   Menicanti, Lorenzo ^a   Castelvecchio, Serenella ^a   De Vincentiis, Carlo ^a   Pistuddi, Valeria ^a  

^a IRCCS POLICLINICO SAN DONATO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; ADULT; AGED; AORTA VALVE PROSTHESIS; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; AORTIC CROSS CLAMP TIME; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR PARAMETERS; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE SEVERITY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART OUTPUT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; PREDICTION; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; AORTA; AORTIC VALVE; AORTIC VALVE STENOSIS; BIOPROSTHESIS; CONSTRICTION; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STROKE VOLUME; SUTURE TECHNIQUES; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 84872064792     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Flameng W, Herregods MC, Hermans H, et al. Effect of sutureless implantation of the Perceval S aortic valve bioprosthesis on intraoperative and early postoperative outcomes. J Thorac Cardiovasc Surg 2011;142:1453-1457
2. Shrestha M, Folliguet T, Meuris B, et al. Sutureless Perceval S aortic valve replacement: A multicenter, prospective pilot trial. J Heart Valve Dis 2009;18:698-702
3. Kumar AB, Suneja M, Bayman EO, Weide GD, Tarasi M. Association between postoperative acute kidney injury and duration of cardiopulmonary bypass: A meta-analysis. J Cardiothorac Vasc Anesth 2012;26:64-69
4. Hedberg M, Boivie P, Engström KG. Early and delayed stroke after coronary surgery - an analysis of risk factors and the impact on short- and long-term survival. Eur J Cardiothorac Surg 2011;40:379-387
5. Guler M, Yamak B, Erdogan M, et al. Risk factors for gastrointestinal complications in patients undergoing coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 2011;25:637-641
6. Roques F, Nashef SA, Michel P, et al. Risk factors and outcome in European cardiac surgery: Analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 1999;15:816-822
7. Ranucci M, Castelvecchio S, Menicanti L, Frigiola A, Pelissero G. The risk of assessing mortality risk in elective cardiac operations. Age, creatinine, ejection fraction and the law of parsimony. Circulation 2009;119:3053-3061
8. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: A report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007;11:R31
9. Blackstone EH, Kirklin JW. Death and other time-related events after valve replacement. Circulation 1985;72:753-767
10. Flameng WJ, Herijgers P, Szecsi J, Sergeant P, Daenen WJ, Scheys I. Determinants of early and late results of combined valve operations and coronary artery bypass grafting. Ann Thorac Surg 1996;61:621-628
11. Michalopoulos A, Tzelepis G, Dafni U, Geroulanos S. determinants of hospital mortality after coronary artery bypass grafting. Chest 1999;115:1598-1603
12. Doenst T, Borger MA, Weisel RD, Yau TM, Maganti M, Rao V. Relation between aortic cross-clamp time and mortality - not as straightforward as expected. Eur J Cardiothorac Surg 2008;33:660-665
13. Al-Sarraf N, Thalib L, Hughes A, et al. Cross-clamp time is an independent predictor of mortality and morbidity in low- and high-risk cardiac patients. Int J Surg 2011;9:104-109
14. Villari B, Hess OM, Kaufmann P, Krogmann OM, Grimm J, Krayenbuehl HP. Effect of aortic valve stenosis (pressure overload) and regurgitation (volume overload) on left ventricular systolic and diastolic function. Am J Cardiol 1992;69:927-934
15. Lorell BH, Grossman W. Cardiac hypertrophy: The consequences for diastole. J Am Coll Cardiol 1987;9:1189-1193
16. Horwich TB, Fonarow GC. Glucose, obesity, metabolic syndrome, and diabetes relevance to incidence of heart failure. J Am Coll Cardiol 2010;55:283-293
17. Campbell DJ, Somaratne JB, Jenkins AJ, et al. Impact of type 2 diabetes and the metabolic syndrome on myocardial structure and microvasculature of men with coronary artery disease. Cardiovasc Diabetol 2011;10:80
18. Herrmann S, Störk S, Niemann M. Low-gradient aortic valve stenosis myocardial fibrosis and its influence on function and outcome. J Am Coll Cardiol 2011;19;58:402-412
19. Kloner RA, Przyklenk K, Shook T, et al. Clinical aspects of preconditioning and implications for the cardiac surgeon. J Card Surg 1995;10(4 Suppl.):369-375
20. Breitenbach I, Wimmer-Greinecker G, Bockeria LA, et al. Sutureless aortic valve replacement with the Trilogy Aortic Valve System: Multicenter experience. J Thorac Cardiovasc Surg 2010;140:878-884, 884.e1
21. Aymard T, Kadner A, Walpoth N, et al. Clinical experience with the second generation 3f Enable sutureless aortic valve prosthesis. J Thorac Cardiovasc Surg 2010;140:313-316
22. Martens S, Ploss A, Sirat S, Miskovic A, Moritz A, Doss M. Sutureless aortic valve replacement with the 3f Enable aortic bioprosthesis. Ann Thorac Surg 2009;87:1914-1917